Skip to main content

Table 1 Demographics

From: uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer

  Celecoxib Dose
  200 mg twice daily
NAF (plasma)
400 mg twice daily
NAF (plasma)
Samples 9 (17) 11 (25)
Age (years)   
Median 46 (51) 51 (50)
Range 23–67 (23–68) 30–68 (30–81)
Menopause   
Pre 2 (4) 5 (11)
Post 7 (13) 6 (14)